Vaccine Safety Datalink Publications

How to search articles by keyword

To search articles on this page by keyword, first click the “open all” tab to list all publications. Then use the “find on this page” function available in most browsers. On desktop, press CTL+F (PC) or CMD+F (Mac) on your keyboard. A “find” text box will open at the top or bottom of your browser. Type the word or phrase you want to search for.

Wang SV, Stefanini K, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub E, Kulldorf M. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Eventexternal icon Drug Saf. Jul 1. Online ahead of print.

Hesse EM, Navarro RA, Daley MF, Getahun D, Henninger ML, Jackson LA, Nordin J, Olson SC, Zerbo O, Zheng C, Duffy J. Risk for Subdeltoid Bursitis After Influenza Vaccination: A Population-Based Cohort Studyexternal icon Ann Intern Med. 2020 Jun 23. Online ahead of print.

Hause AM, Panagiotakopoulos L, Weintraub E, Sy LS, Glenn SC, Tseng HF, McNeil MM. Adverse Outcomes in Pregnant Women Hospitalized with Respiratory Syncytial Virus Infection: A Case-Seriesexternal icon Clin Infect Dis. 2020 Jun 2; ciaa668. Online ahead of print.

Newcomer SR, Daley MF, Narwaney KJ, Xu S, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McLean HQ, Nordin JD, Zerbo O, Glanz JM. Order of Live Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Ageexternal icon Pediatr Infect Dis J. 2020 Mar;39(3):247-253.

Glanz JM, Clarke CL, Xu S, Daley MF, Shoup JA, Schroeder EB, Lewin BL, McClure DL, Kharbanda E, Klein NP, DeStefano F. Association between Rotavirus Vaccine and Type 1 Diabetes in Children.external icon JAMA Pediatr. 2020 Mar 9 [Epub ahead of print].

Li R, Stewart B, Rose C. A Bayesian approach to sequential analysis in post-licensure vaccine safety surveillance.external icon Pharm Stat. 2019 Dec 22. Epub ahead of print

Yu W, Zheng C, Xie F, Chen W, Mercado C, Sy LS, Qian L, Glenn S, Tseng HF, Lee G, Duffy J, McNeil MM, Daley MF, Crane B, McLean HQ, Jackson LA, Jacobsen SJ. The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink.external icon Pharmacoepidemiolo Drug Saf. 2020 Feb;29(2): 182-188 Epub 2019 Dec 3.

Hesse EM, Stanasoff S, Hibbs BF, Adegoke OJ, Ng C, Marquez P, Osborn M, Su JR, Moro PL, Shimbukuro T, Nai N. Shoulder Injury Related to Vaccine Administration (SIRVA): Petitioner Claims to the National Vaccine Injury Compensation Program, 2010-2016.external icon Vaccine. 2020 Jan 29;38(5): 1076-1083. Epub 2019 Nov 22.

Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, Destefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, Belongia EA. Near Real-Time Surveillance to Assess the Safety of the 9-valent Human Papillomavirus Vaccine.external icon Pediatrics. 2019 Dec; 144(6): e20191808. Epub 2019 Nov 18.

Groom HC, Smith N, Irving SA, Koppolu P, Vazquez-Benitez G, Kharbanda EO, Daley MF, Donahue JG, Getahun D, Jackson LA, Klein NP, McCarthy NL, Nordin JD, Panagiotakopoulos L, Naleway AL. Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.external icon Vaccine. 2019 Oct 16;37(44):6648-6655. Epub 2019 Sep 20.

Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, Weintraub ES, Belongia EA. Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.external icon Vaccine. 2019 Oct 16;37(44):6673-6681. Epub 2019 Sep 17.

McNeil MM. Vaccine-Associated Anaphylaxis.external icon Curr Treat Options Allergy. 2019 Sep; 6(3): 297-308. Epub 2019 Jul 16.

Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ, Irving SA, Jackson ML, Lewin B, Liles E, Marin M, Smith N, Weintraub E, Chun C. Incidence of Herpes Zoster Among Children: 2003-2014.external icon Pediatrics. 2019 Jul; 144(1). Pii: e20182917. Epub 2019 Jun 10.

Zheng C, Yu W, Xie F, Chen W, Mercado C, Sy LS, Qian L, Glenn S, Lee G, Tseng HF, Duffy J, Jackson LA, Daley MF, Crane B, McLean HQ, Jacobsen SJ. The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalinkexternal icon, International Journal of Medical Informatics, 2019 Jul; 127(1386-5056): 27-34. Epub 2018 Jun 3.

Hanson KE, McLean HQ, Belongia EA, Stokley S, McNeil MM, Gee J, VanWormer JJ. Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents.external icon Papillomavirus Res. 2019 Dec;8:100168. Epub 2019 May 25.

Hechter RC, Qian L, Tartof SY, Sy LS, Klein NP, Weintraub E, Mercado C, Naleway A, McLean HQ, Jacobsen SJ. Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Projectexternal icon. Vaccine. 2019 May 31; 37(25): 3296-3302. Epub 2019 May 4.

Cook AJ, Wellman RD, Marsh T, Shoaibi A, Tiwari R, Nguyen M, Boudreau D, Weintraub ES, Jackson L, Nelson JS. Applying sequential surveillance methods that use regression adjustment or weighting to control confounding in a multisite, rare-event, distributed setting: Part 2 in-depth example of a reanalysis of the measles-mumps-rubella-varicella combination vaccine and seizure risk.external icon J Clin Epidemiol. 2019 Sep; 113: 114-122. Epub 2019 May 2.

Myers TR, McCarthy NL, Panagiotakopoulos L, Omer SB. Estimation of the Incidence of Guillain-Barré Syndrome During Pregnancy in the United Statesexternal icon, Open Forum Infectious Diseases, 2019 Mar 3; 6(3).

Klein NP, Goddard K, Lewis E, Ross P, Gee J, DeStefano F, Baxter R. Long term risk of developing type 1 diabetes after HPV vaccination in males and females.external icon Vaccine. 2019 Mar 28; 37(14):1938-1944. Epub 2019 Mar 1.

Tartof SY, Qian L, Liu IA, Tseng HF, Sy LS, Hechter RC, Lewin BJ, Jacobsen SJ. Safety of Influenza Vaccination Administered During Hospitalizationexternal icon. Mayo Clin Proc. 2019 Mar; 94(3):397-407. Epub 2019 Jan 8.

McClure DL, Jacobsen SJ, Klein NP, Naleway AL, Kharbanda EO, Glanz JM, Jackson LA, Weintraub ES, McLean HQ. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disordersexternal icon. Vaccine. 2019 Jan 3; 37(1):76-79. Epub 2018 Nov 23.

Groom HC, Irving SA, Koppolu P, Smith N, Vazquez-Benitez G, Kharbanda EO, Daley MF, Donahue JG, Getahun D, Jackson LA, Tse Kawai A, Klein NP, McCarthy NL, Nordin JD, Sukumaran L, Naleway AL. Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink studyexternal icon. Vaccine. 2018 Oct 1; 36(41):6111-6116. Epub 2018 Sep 5.

Naleway AL, Mittendorf KF, Irving SA, Henninger ML, Crane B, Smith N, Daley MF, and Gee J. Incidence of Primary Ovarian Insufficiency and Adolescent Vaccination.external icon Pediatrics 2018 Sep; 142(3). Epub 2018 Aug 21.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Sheth SS, Zhu J, Naleway AL, Klein NP, Hechter R, Daley MF, Donahue JG, Jackson ML, Kawai AT, Sukumaran L, Nordin JD. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.external icon Obstet. Gynecol. 2018 Jul; 132(1): 35-44.

Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.external icon Pharmacoepidemiol. Drug Saf. 2018 Aug; 27(8): 921-925. Epub 2018 Jun 3.

Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM. Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.external icon Biom. J. 2018 Jul; 60(4): 748-760. Epub 2018 May 16.

Tseng HF, Sy LS, Qian L, Liu IA, Mercado C, Lewin B, Tartof SY, Nelson J, Jackson LA, Daley MF, Weintraub E, Klein NP, Belongia E, Liles EG, Jacobsen SJ. Pneumococcal Conjugate Vaccine Safety in Elderly Adults.external icon Open. Forum Infect. Dis. 2018 May 2; 5(6).

Zerbo O, Modaressi S, Goddard K, Lewis E, Fireman BH, Daley MF, Irving SA, Jackson LA, Donahue JG, Qian L, Getahun D, DeStefano F, McNeil MM, Klein NP. Vaccination Patterns in Children After Autism Spectrum Disorder Diagnosis and in Their Younger Siblings.external icon JAMA Pediatr. 2018 May 1; 172(5): 469-475.

Donahue J. Response to three Letters to the Editor regarding: Donahue JG, et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.external icon Vaccine. 35 (2017) 5314-5322. Vaccine. 2018 Apr 19; 36(17): 2231-2232.

Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.external icon Acad. Pediatr. 2018 Sep – Oct; 18(7): 754-762. Epub 2018 Mar 28.

Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age.external icon JAMA. 2018 Mar 6; 319(9): 906-913.

Irving SA, Groom HC, Stokley S, McNeil MM, Gee J, Smith N, Naleway AL. Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.external icon Acad. Pediatr. 2018 Mar; 18(2S): S85-S92.

Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM. Bias From Outcome Misclassification in Immunization Schedule Safety Research.external icon Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):221-228.

Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES. Infant Hospitalizations and Mortality After Maternal Vaccination.external icon Pediatrics. 2018 Mar; 141(3). Epub 2018 Feb 20.

Kuntz J, Crane B, Weinmann S, Naleway AL. Myocarditis and pericarditis are rare following live viral vaccinations in adults.external icon Vaccine. 2018 Mar 14; 36(12): 1524-1527. Epub 2018 Feb 15.

Li R, Weintraub E, McNeil MM, Kulldorff M, Lewis EM, Nelson J, Xu S, Qian L, Klein NP, DeStefano F. Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method.external icon Pharmacoepidemiol. Drug Saf. 2018 Apr; 27(4): 391-397. Epub 2018 Feb 15.

Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay, DK. Estimated rates of influenza-associated outpatient visits during 2001-2010 in six US integrated health care delivery organizations.external icon Influenza. Other Respir. Viruses. 2018 Jan; 12(1): 122-131. Epub 2018 Feb 15.

McNeil MM, DeStefano F. Vaccine-associated hypersensitivityexternal icon. J. Allergy Clin. Immunol. 2018 Feb; 141(2): 463-472.

McNeil MM, Hibbs BF, Miller ER, Cano MV. Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine – United States, 2017.external icon MMWR Morb Mortal Wkly Rep. 2018 Jan 26; 67:109-110.

Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM. Bias from outcome misclassification in immunization schedule safety research.external icon Pharmacoepidemiol. Drug Saf. 2018 Feb; 27(2): 221-228. Epub 2018 Jan 2.

Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz, JM, Jacobsen SJ, Weintraub ES, Klein NP, Gargiullo PM, Fry AM. Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.external icon BMC. Pulm. Med. 2017 Dec 16; 17(1): 208.

Groom HC, Irving SA, Caldwell J, Larsen R, Beaudrault S, Luther LM, Naleway AL. Implementing a Multipartner HPV Vaccination Assessment and Feedback Intervention in an Integrated Health System.external icon J. Public Health Manag. Pract. 2017 Nov/Dec; 23(6): 589-592.

Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J,Weintraub E. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. external iconPharmacoepidemiol Drug Saf. 2018 Jan; 27(1): 59-68. Epub 2017 Nov 17.

Myers TR, McNeil MM, Current safety issues with quadrivalent meningococcal conjugate vaccines.external icon Hum Vaccin Immunother, 2018 May 4; 14(5): 1175-1178; Epub 2017 Nov 8.

McCarthy NL, Sukumaran L, Newcomer S, Glanz J, Daley MF, McClure D, Klein NP, Irving S, Jackson ML, Lewin B, Weintraub E. Patterns of childhood immunization and all-cause mortality.external icon Vaccine. 2017 Dec 4; 35(48 Pt B): 6643-6648. Epub 2017 Oct 20.

VanWormer JJ, Bendixsen CG, Vickers ER, Stokley S, McNeil MM, Gee J, Belongia EA, McLean HQ. Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents.external icon BMC. Public Health. 2017 Oct 2; 17(1): 766.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, and Belongia EA. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12external icon. Vaccine. 2017 Sep 25; 35(40): 5314-5322.

Gee J, Sukumaran L, Weintraub E. Risk of Guillain-Barre Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink.external icon Vaccine. 2017 Oct 13; 35(43): 5756-5758. Epub 2017 Sep 19.

Eaton A, Lewis N, Fireman B, Hansen J, Baxter R, Gee J, Klein, NP. Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.external icon Vaccine 2018 May 3; 36(19): 2733-2739. Epub 2017 Sep 13.

Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA. Risk of venous thromboembolism following influenza vaccination in adults aged 50 years and older in the Vaccine Safety Datalink.external icon Vaccine. 2017 Oct 13; 35(4); 5872-5877. Epub 2017 Sep 6.

Lipkind HS, Vazquez-Benitez G, Nordin JD, Romitti PA, Naleway AL, Klein NP, Hechter RC, Jackson ML, Hambidge SJ, Lee GM, Sukumaran L, Kharbanda EO. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.external icon Obstet. Gynecol. 2017 Sep; 130(3): 599-608.

Duffy J, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, Naleway A, Omer SB, Weintraub E. Febrile Seizure Risk after Vaccination in Children One to Five Months of Age.external icon Pediatr. Neurol. 2017 Nov; 76: 72-78. Epub 2017 Aug 23.

DeSilva M, Vazquez-Benitez G, Nordin JD, Lipkind HS, Klein NP, Cheetham TC, Naleway AL, Hambidge SJ, Lee GM, Jackson ML, McCarthy NL, Kharbanda EO. Maternal Tdap vaccination and risk of infant morbidity.external icon Vaccine 2017 Jun 22; 35(29): 3655-3660. Epub 2017 May 25.

Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, Klein NP, Lee G, Jackson ML, Hambidge SJ, McCarthy N, DeStefano F, Nordin JD. First Trimester Influenza Vaccination and Risks for Major Structural Birth Defects in Offspring.external icon J. Pediatr. 2017 Aug; 187: 234-239. Epub 2017 May 24.

McLean HQ, VanWormer JJ, Chow BDW, Birchmeier B, Vickers E, DeVries E, Meyer J, Moore J, McNeil MM, Stokley S, Gee J, Belongia EA. Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.external icon J. Adolesc. Health. 2017 Aug; 61(2): 252-258. Epub 2017 Apr 24.

Ray GT, Lewis N, Goddard K, Ross P, Duffy J, DeStefano F, Baxter R, Klein NP. Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.external icon Vaccine 2017 May 9; 35(20): 2668-2675. Epub 2017 Apr 9.

Duffy J, Lewis M, Harrington T, Baxter R, Belongia EA, Jackson LA, Jacobsen SJ, Lee GM, Naleway AL, Nordin J, Daley MF. Live attenuated influenza vaccine use and safety in children and adults with asthma.external icon Ann. Allergy Asthma Immunol. 2017 Apr; 118(4): 439-444.

Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.external icon Vaccine. 2017 Apr 4; 35(15): 1873-1878. Epub 2017 Mar 9.

Klein NP, Lewis E, McDonald J, Fireman B, Naleway A, Glanz J, Jackson LA, Donahue, JG, Jacobsen SJ, Weintraub E, Baxter R. Risk factors and familial clustering for fever 7-10 days after the first dose of measles vaccines.external icon Vaccine. 2017 Mar 14; 35(12): 1615-1621. Epub 2017 Feb 21.

Narwaney KJ, Breslin K, Ross CA, Shoup JA, Wain KF, Weintraub ES, McNeil MM, Hambidge SJ. Vaccine adverse events in a safety net healthcare system and a managed care organization.external icon Vaccine. 2017 March 1; 35(9): 1335-1340. Epub 2017 Feb 6.

Hambidge SJ, Ross C, Shoup JA, Wain K, Narwaney K, Breslin K, Weintraub ES, McNeil MM. Integration of data from a safety net health care system into the Vaccine Safety Datalink.external icon Vaccine. 2017 March 1; 35(9): 1329-1334. Epub 2017 Feb 1.

Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, Sivanandam S, Klein NP, Lee GM, Jackson ML, Hambidge SJ, Olsen A, McCarthy N, DeStefano F, Nordin JD. Identifying birth defects in automated data sources in the Vaccine Safety Datalink.external icon Pharmacoepidemiol. Drug Saf 2017 Apr; 26(4): 412-420. Epub 2017 Jan 4.

Sukumaran L, Omer SB. Repeat Tdap Vaccination and Adverse Birth Outcomes–Reply. JAMA 2016;315:1286. https://www.ncbi.nlm.nih.gov/pubmed/27002457external icon

Duffy J, Weintraub E, Hambidge SJ et al. Febrile Seizure Risk After Vaccination in Children 6 to 23 Months. Pediatrics 2016. https://www.ncbi.nlm.nih.gov/pubmed/27802536external icon

Vazquez-Benitez G, Kharbanda EO, Naleway AL et al. Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies. Am J Epidemiol 2016;184:176-186. https://www.ncbi.nlm.nih.gov/pubmed/27449414external icon

Baxter R, Lewis E, Goddard K et al. Acute demyelinating events following vaccines – a case centered analysis. Clin Infect Dis 2016. https://www.ncbi.nlm.nih.gov/pubmed/27585798external icon

DeSilva M, Vazquez-Benitez G, Nordin JD et al. Tdap Vaccination During Pregnancy and Microcephaly and Other Structural Birth Defects in Offspring. JAMA 2016;316:1823-1825. https://www.ncbi.nlm.nih.gov/pubmed/27802536external icon

Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, Daley MF: Vaccine Safety Datalink. White Paper on Studying the Safety of the Childhood Immunization Schedule pdf icon[PDF – 896K]

Kharbanda EO, Vazquez-Benitez G, Lipkind HS et al. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.external icon Vaccine 2016.

McCarthy NL, Gee J, Sukumaran L et al. Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults.external icon Pediatrics 2016;137:1-8.

Tartof SY, Qian L, Rieg GK et al. Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study.external icon Ann Intern Med 2016.

Li R, Stewart B, McNeil MM et al. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.external icon Pharmacoepidemiol Drug Saf 2016.

Gee J, Weinbaum C, Sukumaran L, Markowitz LE. Quadrivalent HPV vaccine safety review and US safety monitoring plans for nine-valent HPV vaccine.external icon Hum Vaccin Immunother 2016;0.

Baxter R, Lewis E, Fireman B, DeStefano F, Gee J, Klein NP. Case-centered analysis of Optic Neuritis following vaccines.external icon Clin Infect Dis 2016.

Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, et al. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006external icon. Vaccine. 2015 Jan 3;33(2):382-7.

Duffy J, Weintraub E, Vellozzi C, DeStefano F; Vaccine Safety Datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United Statesexternal icon. Neurology. 2014 Nov 11;83(20):1823-30. Epub 2014 Oct 15.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomesexternal icon. JAMA. 2014 Nov 12;312(18):1897-904.

Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, et al. Safety of measles-containing vaccines in 1-Year-Old childrenexternal icon. Pediatrics. 2015 Feb;135(2):e321-9. Epub 2015 Jan 5.

McNamara LA, Shumate AM, Johnsen P, MacNeil JR, Patel M, Bhavsar T, et al. First use of a serogroup B meningococcal vaccine in the us in response to a university outbreakexternal icon. Pediatrics. 2015 May;135(5):798-804.

McNeil MM, Weintraub E, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP, et al. Risk of anaphylaxis following vaccination in children and adultsexternal icon. J Allergy Clin Immunol. Epub 2015 Sep 28.

Payne DC, Baggs J, Klein NP, Parashar UD. Does preventing rotavirus infections through vaccination also protect against naturally occurring intussusception over time?external icon Clin Infect Dis. 2015 Jan 1;60(1):163-4.

Stratton KG, Cook AJ, Jackson LA, Nelson JC. Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoringexternal icon. Stat Med. 2015 Mar 30;34(7):1117-33.

Sukumaran L, McCarthy NL, Kharbanda EO, McNeil MM, Naleway AL, Klein NP, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizationsexternal icon. JAMA. 2015 Oct 20;314(15):1581-1587.

Sukumaran L, McCarthy NL, Kharbanda EO, Weintraub ES, Vasquez-Benitez G, McNeil MM, et al. Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy.external icon Obstet Gynecol. 2015 Nov;126(5):1069-74.

Sukumaran L, McCarthy NL, Li R, Weintraub ES, Jacobsen SJ, Hambidge SJ, et al. Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States populationexternal icon. Vaccine. 2015 Aug 26;33(36):4446-50. Epub 2015 Jul 23.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, et al. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccineexternal icon. Vaccine. 2014;32(25):3019-3024.

Duffy J, Weintraub, E, Vellozzi, C, DeStefano F. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United Statesexternal icon. Neurology. 2014;83(20):1823-30.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, et al. Timely versus delayed early childhood vaccination and seizuresexternal icon. Pediatrics. 2014;133(6):e1492-e1499.

Jackson ML, Peterson D, Nelson JC, Greene SK, Jacobsen SJ, Belongia EA, et al. Using winter 2009-2010 to assess the accuracy of methods which estimate influenza-related morbidity and mortalityexternal icon. Epidemiol Infect. 2014 Dec 12:1-9.

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, et al. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012-2013 seasonexternal icon. Pharmacoepidemiol Drug Saf. 2014;23(5):548-553.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomesexternal icon. JAMA. 2014;312(18):1897-1904.

Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway AL, Klein NP, Cheetham TC, et al. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sitesexternal icon. Prev Med. 2014 Oct;67:316-9.

Li R, Stewart B, Weintraub E, McNeil MM. Continuous sequential boundaries for vaccine safety surveillanceexternal icon. Stat Med. 2014 Aug 30;33(19):3387-3397.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, et al. The Vaccine Safety Datalink: Successes and challenges monitoring vaccine safetyexternal icon. Vaccine. 2014 Sep 22;32(42):5390-5398.

Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, et al. Safety of influenza vaccination during pregnancy: A review of subsequent maternal obstetric events and findings from two recent cohort studiesexternal icon. Vaccine. 2014;32(26):3122-3127.

Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, et al. Vaccinations given during pregnancy, 2002-2009: A descriptive studyexternal icon. Am J Prev Med. 2014;46(2):150-157.

Nelson JC, Shortreed SM, Yu O, Peterson D, Baxter R, Fireman B, et al. Integrating database knowledge and epidemiological design to improve the implementation of data mining methods to evaluate vaccine safety in large healthcare databasesexternal icon. Stat Analysis Data Mining. 2014 Oct;7(5):337–351.

Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse eventsexternal icon. Vaccine. 2014 Sep 3;32(39):4985-4992.

Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birthexternal icon. J Pediatr. 2014;164(5):1051-1057.

Tartof SY, Tseng HF, Liu IL, Qian L, Sy LS, Hechter RC, et al. Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizuresexternal icon. Vaccine. 2014;32(48):6408-14.

Tartof SY, Tseng HF, Liu AL, Qian L, Sy LS, Hechter RC, et al. Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohortexternal icon. Vaccine. 2014;32(22):2574-2581.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccinationexternal icon. N Engl J Med. 2014;370(6):513-519.

Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, et al. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series designexternal icon. Biom J. 2014;56(3):513-525.

Duffy J, Weintraub, E, Vellozzi, C, DeStefano F. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United Statesexternal icon. Neurology. 2014;83(20):1823-30.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, et al. Timely versus delayed early childhood vaccination and seizuresexternal icon. Pediatrics. 2014;133(6):e1492-e1499.

Li R, Stewart B, Weintraub E, McNeil MM. Continuous sequential boundaries for vaccine safety surveillanceexternal icon. Stat Med. 2014 Aug 30;33(19):3387-3397.

Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, et al. Vaccinations given during pregnancy, 2002-2009: A descriptive studyexternal icon. Am J Prev Med. 2014;46(2):150-157.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccinationexternal icon. N Engl J Med. 2014;370(6):513-519.

Duffy J, Weintraub, E, Vellozzi, C, DeStefano F. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United Statesexternal icon. Neurology. 2014;83(20):1823-30.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, et al. Timely versus delayed early childhood vaccination and seizuresexternal icon. Pediatrics. 2014;133(6):e1492-e1499.

Li R, Stewart B, Weintraub E, McNeil MM. Continuous sequential boundaries for vaccine safety surveillanceexternal icon. Stat Med. 2014 Aug 30;33(19):3387-3397.

Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, et al. Vaccinations given during pregnancy, 2002-2009: A descriptive studyexternal icon. Am J Prev Med. 2014;46(2):150-157.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccinationexternal icon. N Engl J Med. 2014;370(6):513-519.

Baxter R, Bakshi N, Fireman B, Lewis E, Ray P, et al. Lack of association of Guillain-Barré syndrome with vaccinationsexternal icon. Clin Infect Dis. 2013; 57(2):197-204.

DeStefano F, Price CS, Weintraub ES. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autismexternal icon. J Pediatr. 2013;163(2):561-567.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, et al. International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesexternal icon. Vaccine. 2013;31(40):4448-4458.

Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, et al. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of ageexternal icon. JAMA Pediatr. 2013;167(11):1060-1064.

Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United Statesexternal icon. JAMA Pediatr. 2013;167(3):274-281.

Gold R, Naleway A, Riedlinger K. Factors predicting completion of the human papillomavirus vaccine seriesexternal icon. J Adolesc Health. 2013;52(4):427-432.

Greene SK, Li L, Shay DK, Fry AM, Lee GM, Jacobsen SJ, et al. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010external icon. Pharmacoepidemiol Drug Saf. 2013;22(4):335-344.

Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM,et al. Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: A case-centered analysis in the Vaccine Safety Datalink, 2009-2011external icon. PLoS One. 2013;8(6):e67185.

Henninger M, Crane B, Naleway A. Trends in influenza vaccine coverage in pregnant women, 2008 to 2012external icon. Perm J. 2013;17(2):31-36.

Henninger M, Naleway A, Crane B, Donahue J, Irving S. Predictors of seasonal influenza vaccination during pregnancyexternal icon. Obstet Gynecol. 2013;121(4):741-749.

Iqbal S, Barile JP, Thompson WW, DeStefano F. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 yearsexternal icon. Pharmacoepidemiol Drug Saf. 2013;22(12):1263-1270.

Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, DeStefano F, et al. Trivalent inactivated influenza vaccine and spontaneous abortionexternal icon. Obstet Gynecol. 2013;121(1):159-165.

Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: The 2009 influenza A(H1N1) pandemicexternal icon. Am J Epidemiol. 2013;178(8):1327-1336.

Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, et al. Vaccination site and risk of local reactions in children 1 through 6 years of ageexternal icon. Pediatrics. 2013;131(2):283-289.

Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD, et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric eventsexternal icon. Obstet Gynecol. 2013;122(3):659-667.

Kharbanda EO, Vazquez-Benitez G, Shi WX, Lipkind H, Naleway A, Molitor B, et al. Assessing the safety of influenza immunization during pregnancy: The Vaccine Safety Datalinkexternal icon. Am J Obstet Gynecol. 2012;207(3 Suppl):S47-S51.

McCarthy NL, Gee J, Lin ND, Thyagarajan V, Pan Y, Su S. Evaluating the safety of influenza vaccine using a claims-based health systemexternal icon. Vaccine. 2013;31(50):5975-5982.

McCarthy NL, Irving S, Donahue JG, Weintraub E, Gee J, Belongia E. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalinkexternal icon. Vaccine. 2013;31(49):5822-5826.

McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG. Mortality rates and cause-of-death patterns in a vaccinated populationexternal icon. Am J Prev Med. 2013;45(1):91-97.

Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, et al. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalinkexternal icon. Vaccine. 2013;31(27):2898-2903.

Nelson JC, Yu O, Dominguez-Islas CP, Cook AJ, Peterson D, Greene SK, et al. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: Results of a pentavalent combination DTaP-IPV-Hib vaccine safety studyexternal icon. Am J Epidemiol. 2013;177(2):131-141.

Nelson JC, Marsh T, Lumley T, Larson EB, Jackson LA, Jackson M, et al. Validation sampling can reduce bias in health care database studies: An illustration using influenza vaccination effectivenessexternal icon. J Clin Epidemiol. 2013;66(8 Suppl):S110-S121.

Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young childrenexternal icon. Vaccine. 2013;31(37):3894-3898.

Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, et al. Safety of the yellow fever vaccine: A retrospective studyexternal icon. J Travel Med. 2013;20(6):368-373.

Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant womenexternal icon. Obstet Gynecol. 2013;121(3):519-525.

Qian L, Tseng HF, Sy LS, Jacobsen SJ. Confounder adjustment in vaccine safety studies: Comparing three offset terms for case-centered approachexternal icon. Vaccine. 2013;31(2):431-435.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, et al. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: A meta-analysisexternal icon. Lancet. 2013;381(9876):1461-1468.

Schmidt MA, Gold R, Kurosky SK, Daley MF, Irving SA, Gee J, et al. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink, July 2006-June 2011external icon. J Adolesc Health. 2013;53(5):637-641.

Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, et al. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenexternal icon. Vaccine. 2013;31(22):2578-2583.

Xu S, Hambidge SJ, McClure DL, Daley MF, Glanz JM. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series designexternal icon. Stat Med. 2013;32(19):3290-3299.

Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, et al. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series designexternal icon. Am J Epidemiol.2013;178(12):1750-1759.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, et al. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink project, 2009-2010external icon. Am J Epidemiol. 2012;175(11):1100-1109.

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, et al. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010external icon. Influenza Other Respir Viruses.2012;6(6):e143-e151.

Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in childrenexternal icon. Pediatrics. 2012;129(1):e54-e59.

Hechter RC, Qian L, Sy LS, Greene SK, Weintraub ES, Naleway AL, et al. Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink projectexternal icon. Vaccine. 2012;31(7):1080-1085.

Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, et al. Measles-containing vaccines and febrile seizures in children age 4 to 6 yearsexternal icon. Pediatrics. 2012;129(5):809-814.

McClure DL, Xu S, Weintraub E, Glanz JM. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analysesexternal icon. Vaccine. 2012;30(27):3986-3991.

Naleway AL, Gold R, Drew L, Riedlinger K, Henninger ML, Gee J. Reported adverse events in young women following quadrivalent human papillomavirus vaccinationexternal icon. J Womens Health (Larchmt.). 2012;21(4):425-432.

Rowhani-Rahbar A, Baxter R, Rasgon B, Ray P, Black S, Klein JO, et al. Epidemiologic and clinical features of Bell’s palsy among children in northern Californiaexternal icon. Neuroepidemiology. 2012;38(4):252-258.

Rowhani-Rahbar A, Fireman B, Lewis N, Ray P, Rasgon B, Klein JO, et al. Rowhani-Rahbar et al. respond to “Immunization and Bell’s palsy in children.”external icon Am J Epidemiol. 2012;175(9):888-889.

Rowhani-Rahbar A, Klein NP, Lewis N, Fireman B, Ray P, Rasgon B, et al. Immunization and Bell’s palsy in children: A case-centered analysisexternal icon. Am J Epidemiol. 2012;175(9):878-885.

Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infantsexternal icon. JAMA. 2012;307(6):598-604.

Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, et al. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009)external icon. Neuroepidemiology. 2012;39(2):109-115.

Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM, VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011external icon. Vaccine. 2012;30(11):2024-2031.

Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, et al. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly populationexternal icon. Clin Infect Dis. 2012;56(3):315-321.

Xu S, Zeng C, Newcomer S, Nelson J, Glanz J. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studiesexternal icon. J Biom Biostat. 2012;Suppl 7:006.

Yih WK, Weintraub E, Kulldorff M. No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studiesexternal icon. Pharmacoepidemiol Drug Saf. 2012;21(12):1359-1360.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, et al. The Vaccine Safety Datalink: A model for monitoring immunization safetyexternal icon. Pediatrics. 2011;127(Supp 1):S45-S53.

Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW, et al. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years laterexternal icon. J Pediatr Psychol. 2011;37(1):106-118.

Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalinkexternal icon. Vaccine. 2011;29(46):8279-8284.

Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, et al. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the Vaccine Safety Datalinkexternal icon. Arch Pediatr Adolesc Med.2011;165(8):749-755.

Greene SK, Kulldorff M, Yin R, Yih WK, Lieu TA, Weintraub ES, et al. Near real-time vaccine safety surveillance with partially accrued dataexternal icon. Pharmacoepidemiol Drug Saf. 2011;20(6):583-590.

Hambidge SJ, Ross C, McClure D, Glanz J; VSD team. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohortexternal icon. Vaccine. 2011;29(46):8179-8181.

Jackson LA, Yu O, Nelson JC, Dominguez C, Peterson D, Baxter R, et al. Injection site and risk of medically attended local reactions to acellular pertussis vaccineexternal icon. Pediatrics. 2011;127(3):e581-e587.

Jackson LA, Peterson D, Dunn J, Hambidge SJ, Dunstan M, Starkovichet P. A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infantsexternal icon. PLoS One. 2011;6(6):e20102.

Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillanceexternal icon. Sequential Analysis. 2011;30(1):58-78.

Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink projectexternal icon. Am J Prev Med. 2011;41(2):121-128.

McCarthy NL, Gee J, Weintraub E, Donahue JG, Nordin JD, Daley MF, et al. Monitoring vaccine safety using the Vaccine Safety Datalink: Utilizing immunization registries for pandemic influenzaexternal icon. Vaccine. 2011;29(31):4891-4896.

Mullooly JP, Schuler R, Mesa J, Drew L, DeStefano F; VSD team. Wheezing lower respiratory disease and vaccination of premature infantsexternal icon. Vaccine. 2011;29(44):7611-7617.

Nelson JC, Cook AJ, Yu O, et al. Methods for observational post-licensure medical product safety surveillanceexternal icon. Stat Methods Med Res. Epub 2 Dec 2011.

Ray P, Black S, Shinefield H, et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of ageexternal icon. Vaccine. 2011;29(38):6592-6597.

Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, et al. Safety of zoster vaccine in adults from a large managed care cohort: A Vaccine Safety Datalink studyexternal icon. J Intern Med. 2011;271(5):510-520.

Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, et al. Active surveillance for adverse events: The experience of the Vaccine Safety Datalink projectexternal icon. Pediatrics. 2011;127(Suppl 1):S54-S64.

Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccineexternal icon. Pediatr Infect Dis J. 2010;29(1):1-5.

Donahue JG, Kieke BA, Gargiullo PM, Jumaan AO, Berger NR, McCauley JS, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccinationexternal icon. Am J Public Health. 2010;100(6):1116-1122.

Goodman MJ, Nordin JD, Belongia EA, Mullooly JP, Baggs J, et al. Henöch-Schonlein purpura and polysaccharide meningococcal vaccineexternal icon. Pediatrics. 2010;126(2):e325-e329.

Greene SK, Kulldorff M, Lewis EM, Li R, Yin R, Weintraub ES, et al. Near real-time surveillance for influenza vaccine safety: Proof-of-concept in the Vaccine Safety Datalink projectexternal icon. Am J Epidemiol. 2010;171(2):177-188.

Huang WT, Gargiullo PM, Broder KR, Weintraub ES, Iskander JK, Klein NP, et al. Lack of association between acellular pertussis vaccine and seizures in early childhoodexternal icon. Pediatrics. 2010;126(2):263-269.

Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizuresexternal icon. Pediatrics. 2010;126(1):e1-e8.

Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilanceexternal icon. Stat Med. 2010;29(2):284-295.
Lin ND, Kleinman K, Chan KA, Soumerai S, Mehta J, Mullooly JP, et al. Multiple vaccinations and the risk of medically attended feverexternal icon. Vaccine. 2010;28(25):4169-4174.

Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autismexternal icon. Pediatrics. 2010;126(4):656-664.

Schmidt MA, Crane B, Mullooly JP, Naleway AL. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccineexternal icon. Vaccine. 2010;28(49):7713-7715.

Sy LS, Liu IL, Solano Z, Cheetham TC, Lugg MM, Greene SK, et al. Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organizationexternal icon. Vaccine. 2010 Jul 19;28(32):5254-9.

Xu S, Gargiullo P, Mullooly J, McClure D, Hambidge SJ, Glanz J. Fitting parametric and semi-parametric conditional poisson regression models with Cox’s partial likelihood in self-controlled case series and matched cohort studies.[PDF – 12 pages]external icon J Data Sci. 2010;8:349-360.

Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, et al. Identifying optimal risk windows for self-controlled case series studies of vaccine safetyexternal icon. Stat Med. 2010;30(7):742-752.

Zangwill KM, Yeh SH, Wong EJ, Marcy SM, Eriksen E, Huff KR, et al. Paralytic syndromes in children: epidemiology and relationship to vaccinationexternal icon. Pediatr Neurol. 2010;42(3):206-212.

Batra JS, Eriksen EM, Zangwill KM, Lee M, Marcy SM, Ward JI, et al. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care populationexternal icon. Pediatrics. 2009;123(3):951-958.

Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, et al. Varicella vaccination and ischemic stroke in children: Is there an association?external icon Pediatrics. 2009;123(2):e228-e234.

Greene SK, Shi P, Dutta-Linn MM, Shoup JA, Hinrichsen VL, Ray P, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sitesexternal icon. Am J Prev Med. 2009;37(6):552-555.

Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, et al. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005external icon. Vaccine. 2009;27(17):2335-2341.

Hazlehurst B, Naleway A, Mullooly J. Detecting possible vaccine adverse events in clinical notes of the electronic medical recordexternal icon. Vaccine. 2009;27(14):2077-2083.

Jackson LA, Baxter R, Naleway AL, Belongia EA, Baggs J. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: A Vaccine Safety Datalink studyexternal icon. BMC Infect Dis. 2009;9:37.

Jackson LA, Yu O, Belongia EA, Hambidge SJ, Nelson J, Baxter R. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: A Vaccine Safety Datalink studyexternal icon. BMC Infect Dis. 2009;9:165.

Jackson LA, Yu O, Nelson J, Belongia EA, Hambidge SJ, Baxter R. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: A Vaccine Safety Datalink studyexternal icon. Vaccine. 2009;27(36):4912-4916.

Lorick SA, Fishbein D, Weintraub E, Wortley PM, Lee GM, Zhou F, et al. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonalityexternal icon. BMC Infect Dis. 2009;9:175.

Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM; Vaccine Safety Datalink team. Risk of immune hemolytic anemia in children following immunizationexternal icon. Vaccine. 2009;27(52):7394-7397.

Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: Results from a Vaccine Safety Datalink studyexternal icon. Am J Public Health. 2009;99(Suppl 2):S389-S397.

Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: A review of the available evidenceexternal icon. Expert Rev Vaccines. 2009;8(11):1555-1564.

Shui IM, Shi P, Dutta-Linn MM, Weintraub ES, Hambidge SJ, Nordin JD, et al. Predictive value of seizure ICD-9 codes for vaccine safety researchexternal icon. Vaccine. 2009;27(39):5307-5312.

Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, et al. Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: A probe study using the now-withdrawn rotashield vaccineexternal icon. Pediatrics. 2009;123(3):744-749.

Wei F, Mullooly JP, Goodman M, McCarty MC, Hanson AM, Crane B, et al. Identification and characteristics of vaccine refusersexternal icon. BMC Pediatr. 2009;9:18.

Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalinkexternal icon. Vaccine. 2009;27(32):4257-4262.

Benson PJ, Jackson LA, Rees TG, Dunn JB. Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccineexternal icon. Hum Vaccin. 2008;4(3):234-237.

Clayton HA, Cortes MM, Payne DC, Bartlett DL, Zimmerman LA, Williams WG, et al. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule–United States, February 2006-May 2007. MMWR. 2008;57(15):398-401.

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in childrenexternal icon. Pediatrics. 2008;121(3):e687-e692.

Glanz J, France E, Xu S, Hayes T, Hambidge S, et al. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in childrenexternal icon. Pediatrics. 2008;121(3):e506-e512.

Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007external icon. Pediatrics. 2008;121(6):1206-1212.

Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ, et al. Risk factors for developing apnea after immunization in the neonatal intensive care unitexternal icon. Pediatrics. 2008;121(3):463-469.

McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J, et al. Comparison of epidemiologic methods for active surveillance of vaccine safetyexternal icon. Vaccine. 2008;26(26):3341-3345.

Mullooly JP, Donahue JG, DeStefano F, Baggs J, Eriksen E; VSD Data Quality Working Group. Predictive value of ICD-9-CM codes used in vaccine safety researchexternal icon. Methods Inf Med. 2008;47(4):328-335.

Weinmann S, Chun C, Mullooly JP, Riedlinger K, Houston H, Loparev VN, et al. Laboratory diagnosis and characteristics of breakthrough varicella in childrenexternal icon. J Infect Dis. 2008;197(Suppl 2):S132-S138.

Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalinkexternal icon. J Neurol Sci. 2008; 271(1-2):110-118.

Hinrichsen VL, Kruskal B, O’Brien MA, Lieu TA, Platt R, Vaccine Safety Datalink Team. Using electronic medical records to enhance detection and reporting of vaccine adverse eventsexternal icon. J Am Med Inform Assoc. 2007;14(6):731-735.

Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA, Vaccine Safety Datalink team. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: A cohort studyexternal icon. Pharmacoepidemiol.Drug Saf. 2007;16(7):790-796.

Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineexternal icon. Vaccine. 2007;25(20):4029-4037.

Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, et al. Real-time vaccine safety surveillance for the early detection of adverse eventsexternal icon. Med Care. 2007;45(10 Suppl 2):S89-S95.

Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, et al. Influenza- and RSV-associated hospitalizations among adultsexternal icon. Vaccine. 2007;25(5):846-855.

Mullooly JP, Schuler R, Barrett M, Maher JE. Vaccines, antibiotics, and atopyexternal icon. Pharmacoepidemiol Drug Saf. 2007;16(3):275-288.

Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 yearsexternal icon. N Engl J Med. 2007;357(13):1281-1292.

Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, et al. Hepatitis B vaccine and risk of autoimmune thyroid disease: A Vaccine Safety Datalink studyexternal icon. Pharmacoepidemiol Drug Saf. 2007;16(7):736-745.

Averhoff F, Zucker J, Vellozzi C, Redd S, Woodfill C, Waterman S, et al. Adequacy of surveillance to detect endemic rubella transmission in the United Statesexternal icon. Clin Infect Dis. 2006;43(Suppl 3):S151-S157.

CDC. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine–United States, June 2005-September 2006. MMWR. 2006;55(41):1120-1124.

CDC. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine–United States, October 2005-February 2006. MMWR.2006;55(13):364-366.

France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infantsexternal icon. Arch Pediatr Adolesc Med.2006;160(12):1277-1283.

Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitationsexternal icon. J Clin Epidemiol. 2006;59(8):808-818.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months oldexternal icon. JAMA. 2006;296(16):1990-1997.

Heffelfinger JD, Heckbert SR, Psaty BM, Weiss NS, Thompson WW, Bridges CB, et al. Influenza vaccination and risk of incident myocardial infarctionexternal icon. Hum Vaccin. 2006;2(4):161-166.

Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink populationexternal icon. Vaccine. 2006;24(2):151-156.

Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: A Vaccine Safety Datalink studyexternal icon. Pediatrics. 2006;118(5):2032-2037.

Lieberman P, Camargo CA, Jr., Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: Findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Groupexternal icon. Ann Allergy Asthma Immunol. 2006;97(5):596-602.

Lin ND, Kleinman K, Chan KA, Yu X, France EK, Wei F, et al. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth doseexternal icon. BMC Pediatr. 2006;6:31.

Mullooly JP, Crane B, Chun C. Trivalent inactivated influenza vaccine safety in children: Assessing the contribution of telephone encountersexternal icon. Vaccine. 2006;24(13):2256-2263.

Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old childrenexternal icon. J Infect Dis.2006;194(8):1032-1039.

Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548-1558.

Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, et al. Encephalopathy after whole-cell pertussis or measles vaccination: Lack of evidence for a causal association in a retrospective case-control studyexternal icon. Pediatr Infect Dis J. 2006;25(9):768-773.

Belongia EA, Naleway A, Kieke B, Qutaishat S, Casey C, et al. Validation of a screening instrument to identify persons for exclusion from smallpox vaccinationexternal icon. Clin Infect Dis. 2005;40(4):620-623.

Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, et al. Active surveillance of vaccine safety: A system to detect early signs of adverse eventsexternal icon. Epidemiology. 2005;16(3):336-341.

DeStefano F, Weintraub ES, Chen RT. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective studyexternal icon. Neurology. 2005;64(7):1317.

Hazlehurst B, Mullooly J, Naleway A, Crane B. Detecting possible vaccination reactions in clinical notesexternal icon. AMIA Annu Symp Proc. 2005:306-310.

Jackson LA, Neuzil KM, Whitney CG, Starkovich P, Dunstan M, Yu O, et al. Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineexternal icon. Vaccine. 2005;23(28):3697-3703.

Lewis N, Black S, Weintraub E, Baggs J, Thompson W, DeStefano F, et al. Rapid assessment of influenza vaccination coverage among HMO members–northern California influenza seasons, 2001-02 through 2004-05. MMWR. 2005;54(27):676-678.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Xu S, et al. Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infantsexternal icon. BMC Pediatr. 2005;5:43.

Mell LK, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996-1999external icon. Pediatrics. 2005;115(2):461-467.

Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002[PDF – 120 KB]external icon. Epidemiol Infect.2005;133(2):245-253.

Prosser LA, Bridges CB, Uyeki TM, Rêgo VH, Ray GT, Meltzer MI, et al. Values for preventing influenza-related morbidity and vaccine adverse events in childrenexternal icon. Health Qual Life Outcomes. 2005;3:18.

Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infantsexternal icon. Am J Perinatol. 2004;21(6):333-339.

Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organizationexternal icon. J Allergy Clin Immunol. 2004;113(3):536-542.

Eriksen EM, Perlman JA, Miller A, Marcy SM, Lee H, Vadheim C, et al. Lack of association between hepatitis B birth immunization and neonatal death: A population-based study from the Vaccine Safety Datalink projectexternal icon. Pediatr Infect Dis J. 2004;23(7):656-662.

France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, et al. Safety of the trivalent inactivated influenza vaccine among children: A population-based studyexternal icon. Arch Pediatr Adolesc Med. 2004;158(11):1031-1036.

Maher JE, Mullooly JP, Drew L, DeStefano F. Infant vaccinations and childhood asthma among full-term infantsexternal icon. Pharmacoepidemiol Drug Saf. 2004;13(1):1-9.

Mullooly J, Drew L, DeStefano F, Maher J, Bohlke K, Immanuel V, et al. Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safetyexternal icon. Methods Inf Med. 2004;43(2):163-170.

Mullooly JP, Maher JE, Drew L, et al. Evaluation of the impact of an HMO’s varicella vaccination program on incidence of varicellaexternal icon. Vaccine. 2004;22(11-12):1480-1485.

O’Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young childrenexternal icon. Pediatrics. 2004;113(3 Pt 1):585-593.

Spector L, Groves F, DeStefano F, Liff J, Klein M, Mullooly J, et al. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemiaexternal icon. Eur J Cancer. 2004;40(4):579-584.

Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, et al. Risk of anaphylaxis after vaccination of children and adolescentsexternal icon. Pediatrics. 2003;112(4):815-820

DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, et al. Vaccinations and risk of central nervous system demyelinating diseases in adultsexternal icon. Arch Neurol. 2003;60(4):504-509.

Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adultsexternal icon. N Engl J Med. 2003;348(18):1747-1755.

Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, et al. Polio extraimmunization in children younger than 2 years after changes in immunization recommendationsexternal icon. Pediatrics. 2003;111(2):296-301.

Naleway AL, Belongia EA, Greenlee RT, Kieke BA Jr, Chen RT, Shay DK. Eczematous skin disease and recall of past diagnoses: Implications for smallpox vaccinationexternal icon. Ann Intern Med. 2003;139(1):1-7.

Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al. Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databasesexternal icon. Pediatrics. 2003;112(5):1039-1048.

Verstraeten T, Jumaan AO, Mullooly JP, Seward JF, Izurieta HS, DeStefano F, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccinationexternal icon. Pediatrics. 2003;112(2):e98-103.

Verstraeten T, DeStefano F, Chen RT, Miller E. Vaccine safety surveillance using large linked databases: Opportunities, hazards and proposed guidelinesexternal icon. Expert Rev Vaccines. 2003;2(1):21-29.

Yih WK, Lieu TA, Rego VH, O’Brien MA, Shay DK, Yokoeet DS, et al. Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccinationexternal icon. BMC Public Health. 2003;3:20.

Black SB, Lewis E, Shinefield HR, Fireman B, Ray P, et al. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: Long term follow-up of the HbOC efficacy trial cohortexternal icon. Pediatr Infect Dis J. 2002;21(6):568-569.

Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: Implications for use of attenuated rotavirus vaccinesexternal icon. Pediatr Infect Dis J. 2002;21(2):97-102.

DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, et al. Childhood vaccinations and risk of asthmaexternal icon. Pediatr Infect Dis J. 2002;21(6):498-504.

DeStefano F, Verstraeten T, Chen RT. Hepatitis B vaccine and risk of multiple sclerosisexternal icon. Expert Rev Vaccines. 2002;1(4):461-466.

Gonzalez IM, Averhoff FM, Massoudi MS, Yusuf H, DeStefano F, Kramarz P, et al. Hepatitis B vaccination among adolescents in 3 large health maintenance organizationsexternal icon. Pediatrics. 2002;110(5):929-934.

Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary eventsexternal icon. Am J Epidemiol. 2002;156(7):634-640.

Mullooly JP, Pearson J, Drew L, Schuler R, Maher J, Gargiullo P, et al. Wheezing lower respiratory disease and vaccination of full-term infantsexternal icon. Pharmacoepidemiol Drug Saf. 2002;11(1):21-30.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccineexternal icon. N Engl J Med. 2001;345(9):656-661.

Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs B. Challenges and controversies in immunization safetyexternal icon. Infect Dis Clin North Am. 2001;15(1):21-39, viii.

Davis RL, Lieu TA, Mell LK, Capra AM, Zavitkovsky A, Quesenberry CP Jr, et al. Impact of the change in polio vaccination schedule on immunization coverage rates: A study in two large health maintenance organizationsexternal icon. Pediatrics. 2001;107(4):671-676.

Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: A case-control study from the Vaccine Safety Datalink projectexternal icon. Arch Pediatr Adolesc Med. 2001;155(3):354-359.

Davis RL, Bohlke K. Measles vaccination and inflammatory bowel disease: Controversy laid to rest?external icon Drug Saf. 2001;24(13):939-946.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitusexternal icon. Pediatrics. 2001;108(6):E112.

DeStefano F. The Vaccine Safety Datalink projectexternal icon. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406.

Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectorsexternal icon. Vaccine. 2001;19(32):4703-4709.

Kramarz P, DeStefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children?external icon J Pediatr. 2001;138(3):306-310.

Kramarz P, France EK, DeStefano F, Black SB, Shinefield H, Ward JI, et al. Population-based study of rotavirus vaccination and intussusceptionexternal icon. Pediatr Infect Dis J. 2001;20(4):410-416.

Lewis E, Shinefield HR, Woodruff BA, Black SB, Destefano F, Chen RT. Safety of neonatal hepatitis B vaccine administrationexternal icon. Pediatr Infect Dis J. 2001;20(11):1049-1054.

Lieu TA, Davis RL, Capra AM, Mell LK, Quesenberry CP, Martin KE, et al. Variation in clinician recommendations for multiple injections during adoption of inactivated polio vaccineexternal icon. Pediatrics. 2001;107(4):E49.

Belay ED, Holman RC, Clarke MJ, Destefano F, Shahriari, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizationsexternal icon. Pediatr Infect Dis J. 2000;19(9):828-832.

Chen RT, DeStefano F, Davis RL. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the USpdf iconexternal icon. Bull World Health Organ. 2000;78(2):186-194.

Chen RT, Mootrey G, DeStefano F. Safety of routine childhood vaccinations: An epidemiological reviewexternal icon. Paediatr Drugs 2000; 2:273-290.

DeStefano F. Opportunities for population-based clinical research using data from managed care organizationsexternal icon. In: Davis JR, ed. Managed Care Systems and Emerging Infections. Washington, D.C.: National Academy Press, 2000: 16-18.

Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young childrenexternal icon. N Engl J Med. 2000;342(4):232-239.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthmaexternal icon. Arch Fam Med. 2000;9(7):617-623.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, et al. Influenza vaccination in children with asthma in health maintenance organizationsexternal icon. Vaccine. 2000;18(21):2288-2294.

Kuppermann M, Nease RF, Jr., Ackerson LM, Black SB, Shinefield HR, Lieu TA. Parents’ preferences for outcomes associated with childhood vaccinationsexternal icon. Pediatr Infect Dis J. 2000;19(2):129-133.

Lieu TA, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG. The hidden costs of infant vaccinationexternal icon. Vaccine. 2000;19(1):33-41.

Davis RL, Rubanowice D, Shinefield HR, Lewis N, Gu D, Black SB, et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization statusexternal icon. JAMA. 1999;282(6):547-553.

DeStefano F, Chen RT. Negative association between MMR and autismexternal icon. Lancet. 1999;353(9169):1987-1988.

Gargiullo PM, Kramarz P, DeStefano F, Chen RT. Principles of epidemiological research on drug effectsexternal icon. [Letter] Lancet. 1999;353(9151):501.

Jackson LA, Benson P, Sneller VP, Butler JC, Thompson RS, Chen RT, et al. Safety of revaccination with pneumococcal polysaccharide vaccineexternal icon. JAMA. 1999;281(3):243-248.

Mullooly J, Drew L, DeStefano F, Chen R, Okoro K, Swint E, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safetyexternal icon. Am J Epidemiol. 1999;149(2):186-194.

Davis RL, Mell LK, Zavitkovsky A, Thompson RS, Lieu TA, Capra AM, et al. Impact of the sequential IPV/OPV schedule on vaccination coverage levels–United States, 1997. MMWR. 1998;47(47):1017-1019.

Lieu TA, Black SB, Takahashi H, Ray P, Capra AM, Shinefield HR, et al. Varicella serology among school age children with a negative or uncertain history of chickenpoxexternal icon. Pediatr Infect Dis J. 1998;17(2):120-125.

Lieu TA, Capra AM, Makol J, Black SB, Shinefield HR. Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organizationexternal icon. Pediatrics. 1998;101(4):E3.

Niu MT, Rhodes P, Salive M, Lively T, Davis DM, Black S, et al. Comparative safety of two recombinant hepatitis B vaccines in children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)external icon. J Clin Epidemiol. 1998;51(6):503-510.

Parashar UD, Holman RC, Bresee JS, Clarke MJ, Rhodes PH, Davis RL, et al. Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizationsexternal icon. Pediatr Infect Dis J. 1998;17(7):605-611.

Udovic SL, Lieu TA, Black SB, Ray PM, Ray GT, Shinefield HR. Parent reports on willingness to accept childhood immunizations during urgent care visitsexternal icon. Pediatrics. 1998;102(4):E47.

Barlow WE. Global measures of local influence for proportional hazards regression modelsexternal icon. Biometrics. 1997;53(3):1157-1162.

Black S, Shinefield H, Ray P, Lewis E, Chen R, et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: An analysis of the Vaccine Safety Datalink (VSD) Projectexternal icon. Pediatr Infect Dis J. 1997;16(5):500-503.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United Statesexternal icon. Pediatrics. 1997;99(6):765-773.

Davis RL, Marcuse E, Black S, Shinefield H, Givens B, Schwalbe J, et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: A comparison of adverse clinical events after immunization in the Vaccine Safety Datalink projectexternal icon. Pediatrics. 1997;100(5):767-771.

Davis RL, Black S, Vadheim C, Shinefield H, Baker B, Pearson D, et al. Immunization tracking systems: Experience of the CDC Vaccine Safety Datalink sitesexternal icon. HMO Pract. 1997;11(1):13-17.

Lieu TA, Black SB, Ray P, Schwalbe JA, Lewis EM, Lavetter A, et al. Computer-generated recall letters for underimmunized children: How cost-effective?external icon Pediatr Infect Dis J. 1997;16(1):28-33.

Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, et al. Risk of chronic arthropathy among women after rubella vaccinationexternal icon. JAMA. 1997;278(7):551-556.

Barlow W. Measurement of interrater agreement with adjustment for covariatesexternal icon. Biometrics.1996;52(2):695-702.

Lieu TA, Black SB, Sorel ME, Ray P, Shinefield HR. Would better adherence to guidelines improve childhood immunization rates?external icon Pediatrics. 1996;98(6 Pt 1):1062-1068.

Mullooly JP. Misclassification model for person-time analysis of automated medical care databasesexternal icon. Am J Epidemiol. 1996;144(8):782-792.

Thompson RS. What have HMOs learned about clinical prevention services? An examination of the experience at Group Health Cooperative of Puget Soundexternal icon. Milbank Q. 1996;74(4):469-509.

Wassilak SG, Glasser JW, Chen RT, Hadler SC. Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effectsexternal icon. Ann NY Acad Sci. 1995;754:377-382.

Lieu TA, Black SB, Ray P, Chellino M, Shinefield HR, Adleret NE. Risk factors for delayed immunization among children in an HMOexternal icon. Am J Public Health. 1994;84(10):1621-1625.

Pearson DC, Thompson RS. Evaluation of Group Health Cooperative of Puget Sound’s Senior Influenza Immunization Programexternal icon. Public Health Rep. 1994;109(4):571-578.